LAMP3 and esophageal squamous cell carcinoma: Moreover, LAMP3 is considered a suitable biomarker for breast cancer as it is associated with the progress regulating hypoxia [65], and its expression in epithelial cells is reported to evaluate the prognosis of esophageal squamous cell carcinoma [66].